While these medications are generally well-tolerated, specific adverse effects and monitoring parameters warrant clinical vigilance
Contraindications that apply regardless of dose: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Prior serious hypersensitivity to tirzepatide Pregnancy or breastfeeding Active pancreatitis or a history of severe pancreatitis Severe gastroparesis Adverse events that can occur at any dose: nausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder disease, acute kidney injury from dehydration, injection-site reactions, and rare cases of pancreatitis
If you have type 2 diabetes this may be gone after one day and you may not need your blood pressure tablets
Research has highlighted its effects on body weight, glucose metabolism, hepatic fat reduction, and energy expenditure, with the glucagon component adding a thermogenic dimension that distinguishes it from earlier single- and dual-agonist compounds
Both are short-acting and WADA-prohibited
Its important to schedule routine follow-up visits with the medical professional to evaluate the dosages continued efficacy